
    
      A prospective, Non-Randomized, Single-arm, Multi-center, Clinical Study to Evaluate the
      Safety and Performance of the DynalinkÂ®-E, Everolimus Eluting Peripheral Stent System for the
      Treatment of Atherosclerotic de Novo or Restenotic Native Superficial Femoral and Proximal
      Popliteal Artery Lesions.
    
  